Clinical Evaluation of the Nucleus 5 Cochlear Implant (CI) System

NCT01072409 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2016-10-27

Study results available
· View outcomes & findings →

Summary

To evaluate the performance of the Nucleus 5 Cochlear Implant System.

Conditions

Interventions

DEVICE

Nucleus 5 Cochlear implant

Cochlear implant surgery

DEVICE

Cochlear implantation

Implantation

Sponsors & Collaborators

  • Cochlear

    lead INDUSTRY

Principal Investigators

  • Teresa Zwolan, PhD · University of Michigan

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01072409 on ClinicalTrials.gov